EDGAR Filing Documents for 0001225208-10-021219

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001225208-10-021219

Filing Date

2010-09-22

Accepted

2010-09-22 11:45:09

Documents

Period of Report

2010-09-16

Document Format Files

Seq	Description	Document	Type	Size
1		doc4.html	4
1		doc4.xml	4	7710
	Complete submission text file	0001225208-10-021219.txt		9520

Mailing Address P.O. BOX 110526 RESEARCH TRIANGLE PARK NC 27709

Business Address 4101 RESEARCH COMMONS 79 T.W. ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 919-316-6300

Talecris Biotherapeutics Holdings Corp. (Issuer) CIK: 0001405197 (see all company filings)

IRS No.: 202533768 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 79 TW ALEXANDER DRIVE 4101 RESEARCH COMMONS RESEARCH TRIANGLE PARK NC 27709

Business Address

Type: 4 | Act: 34 | File No.: 001-34473 | Film No.: 101084150